The 18 analysts offering 12-month price forecasts for Pfizer Inc have a median target of 42.00, with a high estimate of 53.00 and a low estimate of 36.00. The median estimate represents a +5.34% increase from the last price of 39.87.
The current consensus among 22 polled investment analysts is to Hold stock in Pfizer Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.95
Reporting Date Aug 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.